Haruto Kurata
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391).Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto
|Jun 16, 2025
Correction to "Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator In Vivo Tool Compound".Kentaro Yashiro, Yuzo Iwaki, Hirohito Urata
|May 14, 2025
Discovery of ONO-TR-772 (VU6018042): A Highly Selective and CNS Penetrant TREK Inhibitor in Vivo Tool Compound.Motoyuki Tanaka, Takahiro Mori, Gakuji Hashimoto
|Feb 21, 2025
Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator In Vivo Tool Compound.Kentaro Yashiro, Yuzo Iwaki, Hirohito Urata
|Sep 23, 2024
Journal of Medicinal Chemistry Collection: Drug Discovery in Japan.Takayoshi Suzuki, Haruto Kurata, Tomohiko Ohwada
|Nov 10, 2017
Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases.Haruto Kurata, Kensuke Kusumi, Kazuhiro Otsuki
Pageof 1
